US Patent Issued to Ablynx, Sanofi on June 23 for "Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains" (Belgian, German Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,525, issued on June 23, was assigned to Ablynx N.V. (Ghent-Zwijnaarde, Belgium) and Sanofi (Paris).

"Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains" was invented by Judith Baumeister (Mechelen, Belgium), Marie-Paule Lucienne Armanda Bouche (Gentbrugge, Belgium), Carlo Boutton (Wielsbeke, Belgium), Marie-Ange Buyse (Merelbeke, Belgium), Veerle Snoeck (Zingem, Belgium), Stephanie Staelens (Wevelgem, Belgium), Bruno Dombrecht (Heusden, Belgium), Peter Schotte (De Pinte, Belgium), Cedric Jozef Neotere Ververken (Merelbeke, Belgium), Gerald Beste (Ghent, Belgium), Guy Hermans (Merelbeke, Belgiu...